AIImpactLab
9 impact clustersWork & marketsCognition & learningTechnical failuresPrivacySecurityEnvironmentLaw & informationSocial good & healthSystemic risk
Search the evidence

Find the signal.

Search titles, impact clusters, countries, organizations and the full text of every analysis.

9 stories found

A polished AI-generated medical note floats over a patient conversation while missing clinical facts glow in the gaps.
Social good & healthUnited Kingdom and international healthcare+4 clusters01

AI scribes save clinicians time while hiding errors inside fluent notes

Ambient AI scribes are spreading faster than the evidence needed to govern them. A new British Dental Journal literature review searched research published from January 2015 through December 2025, screened 3,036 records, and included 57 studies. Only three focused on dentistry. The systems can reduce documentation burden and may improve burnout measures, but fluent notes can conceal omissions, substitutions, and hallucinations that are harder to notice precisely because the prose reads well. In one dental speech-recognition study, an experimental system reached a 3.7 percent word-error rate and the strongest commercial product reached 5.4 percent, yet clinically meaningful mistakes remained, including changing “16 hours” to “10 minutes.” Across wider healthcare research cited by the review, one analysis found hallucinations in 1.47 percent of note sentences and omissions corresponding to 3.45 percent of transcript sentences. Those figures are not universal error rates; studies used different systems, specialties, and definitions. The severity evidence is still sobering: 44 percent of hallucinated sentences and 16.7 percent of omissions in that study were classified as capable of major harm. Human review reduced clinically significant errors from 63.6 percent to 7.8 percent in another cited study, but that shifts clinicians from writers to editors and potential liability sinks. Patient attitudes also depend on disclosure. Favorability toward ambient documentation fell when people received fuller information about how it works. The technology may genuinely return attention to the patient. Its success will depend on whether saved typing time becomes careful verification time rather than disappearing from the workflow.

11 min
Ink-wash diagnostic lens bringing case cards into focus while a larger human silhouette remains incomplete.
Social good & healthGlobal+1 clusters02

A striking diagnosis score. Not a licence to replace doctors.

Microsoft's diagnostic result deserves excitement and a careful reading. In its October 22 account of the research, Microsoft reports that MAI-DxO reached 83% diagnostic accuracy on complex New England Journal of Medicine cases, compared with 36% for physicians allowed external reference resources. The company also reports a strong result on a separate set of emergency-department cases. These are promising results for a system that works through diagnostic questions, rather than simply guessing from a finished vignette. But the setting matters. The comparisons used controlled simulations and historical cases, not a prospective trial showing improved outcomes for patients receiving care. Generalist physicians are not the same comparator as a specialist team with a physical examination, a full clinical workflow and responsibility for treatment. Microsoft's benchmark documentation also explains that its gatekeeper can supply plausible information when the underlying case record does not contain a requested detail. That does not make the experiment worthless. Controlled comparisons help identify capabilities worth testing. It does mean that a diagnostic score should not silently become a claim about clinical safety, replacement of clinicians or money already saved in hospitals. The encouraging next step is the one Microsoft itself describes: prospective evaluation with Beth Israel Deaconess. Our question is not whether an AI can look impressive on a benchmark. It is whether assistance improves decisions and outcomes when the patient, the uncertainty and the consequences are real.

4 min
A hand selects a lens beside a notebook, representing clinical checking and independent understanding.
Social good & healthGlobal+2 clusters03

A better AI answer can still need a better human check.

There is something genuinely encouraging in the new clinical reasoning study: the human check was not merely ceremonial. It helped improve the result. There is also a warning against judging a system by the right answers alone. The Nature Communications paper compares six matched pairs of reasoning and standard language models on retrospective clinical records. Reasoning models were better at including the primary diagnosis, but they also suggested more false-positive diagnoses. A separate validation exercise with fifteen physicians found benefits from structured collaboration. These are controlled retrospective findings, not proof of improved outcomes for patients in routine care. That distinction changes the design question. A longer list of plausible diagnoses can help a clinician consider something overlooked. It can also create unnecessary work if the extra possibilities are treated as conclusions. The quality of the workflow depends on how suggestions are challenged, not just how many the model can produce. The second paper, in Communications Psychology, addresses a related but different problem. Its SYNC framework separates performance with AI assistance from durable human learning. It is a Perspective proposing mechanisms and practices, not a new trial proving that a particular intervention works. I read the two together as an invitation to ask three questions. Did assistance improve the task? Were the additional errors caught? Can the person still explain and apply the reasoning without the tool later? The clinical paper offers evidence relevant to the first two. The learning framework gives a vocabulary for investigating the third. That is an editorial comparison, not a claim that one study validates the other. We can welcome useful assistance while refusing to let a polished answer stand in for either safety or understanding.

4 min
A clinician checks an AI evidence interface while weighing a treatment decision in a hospital.
Social good & healthUnited States+3 clusters04

Doctors are asking AI how to treat patients. Are we testing the right thing?

A doctor wondering which treatment to choose is a more consequential scene than an AI acing a diagnostic quiz. A new JAMA study analyzed 271 million questions submitted by 952,008 verified US clinicians to OpenEvidence between January 2024 and June 2026. Among physicians' queries, 33.1% concerned treatment and management, while 13.9% concerned diagnosis. More than half were categorized as clinical decision-making. Monthly active users rose from 355 to 703,265 over the study period, though that is growth on one platform, not a count of all US clinicians using AI. The authors say early-career physicians and nonprocedural specialties used it disproportionately. That should change the evaluation agenda. A tool can score well on diagnostic vignettes and still give weak medication guidance, omit a contraindication or misread an evolving guideline. The study did not examine the answers, clinical decisions or patient outcomes, and it could not tell whether a question was asked at the bedside or in preparation. Its topic labels came from a model, with a small clinician validation sample, and several authors disclosed employment at the platform. Those limits do not make the usage pattern unimportant; they make independent treatment-focused testing more urgent. The next studies should compare AI-assisted and usual-care decisions on real treatment tasks, measure errors as well as speed, and ask whether patients are better off. For now, the accurate headline is not that AI treats patients. It is that clinicians are increasingly asking it treatment questions before we have strong public evidence for those answers.

6 min
A student organizes a difficult assignment across planning sheets while a luminous bridge connects a tangled task pile to a clear next step.
Cognition & learningUnited Kingdom+2 clusters05

For some neurodivergent students, generative AI is an access layer before it is a shortcut

A useful debate about AI in education has to make room for the student who is not trying to evade thinking. A new peer-reviewed qualitative study from King's College London observed 24 university students—12 neurodivergent and 12 neurotypical—completing an academic task with Microsoft Copilot, then held focus groups with 14 participants. Both groups used generative AI strategically, but neurodivergent participants explicitly described using it to manage energy and cognitive processing demands. In the neurodivergent focus group, some called it essential scaffolding for academic work. The same participants did not describe a frictionless solution. They raised tensions around authenticity and over-reliance, while the researchers reported that interface-design problems seemed especially difficult for users with executive-function differences. This is a small, qualitative sample. It cannot tell us how common these experiences are, whether grades improved, whether independent learning weakened, or how effects differ across diagnoses and courses. Its value is different: it reveals a policy category that blanket bans miss. For one student, AI may substitute for the work an assessment is designed to measure. For another, it may substitute for an avoidable barrier and make the actual reasoning visible. Institutions need assessments that ask students to explain choices, document AI use and demonstrate understanding, paired with accessible interfaces and human support. The goal should not be to label AI as accommodation or cheating in advance. It should be to identify what cognitive work the student must own and what scaffolding lets them perform it.

5 min
A patient reviews clear AI-prepared questions before meeting a surgeon, with an anxiety gauge and consultation timer both falling.
Social good & healthChina+4 clusters06

A local AI briefing cut pre-surgery anxiety and physician workload

A randomized phase II study offers a bounded example of medical AI that helped without pretending to replace the clinician. Researchers assigned 268 people newly diagnosed with prostate cancer and scheduled for radical prostatectomy to standard communication or an AI-assisted pathway. The intervention used a locally deployed large language model to prepare personalized answers to patient questions before the routine face-to-face discussion. Physicians remained responsible for the encounter and were blinded to group assignment. The AI-assisted group reported a mean post-communication GAD-7 anxiety score of 3.2, compared with 5.7 in the control group. Physician workload on the NASA-TLX scale averaged 39.9 versus 56.8, and routine communication time fell from 19.9 to 11.3 minutes. Satisfaction, emotions, and illness perceptions also improved. This is stronger evidence than a product testimonial, but it is not a general verdict on AI in medicine. The study was conducted at one cancer center, used a specific preoperative setting, measured near-term outcomes, and does not establish diagnostic accuracy, surgical outcomes, or long-term safety. The trial registry also still shows an earlier estimated enrollment of 160 and future completion dates, while the published paper reports 268 randomized participants; that record mismatch should be clarified. The design’s most important feature is the boundary: the model answered common questions in advance, responses were reviewed, and the surgeon still conducted the consent conversation. AI did not replace the relationship. It gave the relationship a better starting point.

10 min
A conventional microscope with a compact motorized stage scans a bone-marrow slide and routes candidate-cell evidence to a gloved clinical reviewer.
Social good & healthUnited States and Global+3 clusters07

A low-cost self-driving microscope screens bone marrow slides for acute leukemia

A Nature Communications study presents ALLocate, a low-cost AI-powered plugin that turns a conventional microscope into a self-driving screening system for acute leukemia. The system automatically selects useful bone-marrow regions, detects cells, and produces a slide-level result without a whole-slide scanner. Researchers trained and evaluated it with more than 11,000 annotated regions and 130,000 annotated cells, then used independent multi-institutional cohorts that included 165 physical bone-marrow smear slides. Reported performance exceeded 0.99 AUROC for region selection, reached 0.90 mean average precision for cell detection, and achieved 88 percent accuracy for diagnosis on glass slides. That combination could make automated screening more accessible where scanners and specialist expertise are scarce. It does not support an autonomous final diagnosis. An 88 percent result leaves clinically important errors, and the study does not erase the need for population-specific validation, slide-quality checks, calibration, human confirmation, and escalation to a pathologist. The strongest deployment is a lower-cost bridge to expertise, not a substitute for it.

5 min
A stylized exam room conversation becomes a medical chart with visible AI insertions, a consent control, privacy lock, and physician correction trail.
Social good & healthUnited States · Europe+3 clusters08

Ambient AI medical scribes enter exam rooms before consent and traceability catch up

Ambient AI systems that listen to clinician-patient conversations and draft medical notes are already widespread across hospitals in the United States and Europe, according to experts interviewed by ABC13 and republished by Yahoo. The appeal is immediate: a clinician can look at the patient instead of a screen, reduce after-hours documentation, and start from a structured draft. The risk is equally concrete because the draft becomes part of a durable medical record. Patients may not always receive meaningful notice, models can omit or invent details, and unclear data practices can expose intimate conversations. Houston Methodist told the outlet that every generated note is reviewed, edited, and approved by the physician, who remains responsible. That is a necessary control, not a complete governance system. Health systems should preserve the source transcript, identify AI-generated passages, record edits and model versions, disclose data access and retention, obtain informed consent, and give patients a practical way to correct the record.

5 min
A wearable bioelectronic patch linking biosensing, an AI decision node, human oversight, and controlled therapy in a closed loop.
Social good & healthGlobal+2 clusters09

Gao et al., “AI-powered closed-loop wearable bioelectronics for personalized and autonomous healthcare”

A Nature Sensors review argues that AI-powered closed-loop wearables could move healthcare devices beyond passive data collection by connecting continuous biosensing directly to AI-guided decisions and therapeutic intervention. The authors emphasize that clinical value depends on the coordinated system—sensing, control, treatment, and human oversight—not any component alone. Long-term interface stability, robust control, transparent safety mechanisms, and evidence of patient benefit remain prerequisites for scalable use.

3 min